Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort …
…, T Thongmee, C Auphimai… - Human vaccines & …, 2022 - Taylor & Francis
In light of intermittent supply shortages of individual vaccines and evidence of rare but serious
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination
…, N Suntronwong, C Auphimai… - The Journal of …, 2022 - academic.oup.com
Background The use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated …
…, S Assawakosri, N Suntronwong, C Auphimai… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
…, T Thongmee, P Vichaiwattana, C Auphimai… - Vaccine, 2022 - Elsevier
In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
High prevalence of coxsackievirus A2 in children with herpangina in Thailand in 2015
J Chansaenroj, C Auphimai, J Puenpa… - Virusdisease, 2017 - Springer
Coxsackievirus (CV) is a member of the genus Enterovirus and the family Picornaviridae. CV
infection can cause herpangina, a disease characterized by multiple ulcers on the tonsils …
infection can cause herpangina, a disease characterized by multiple ulcers on the tonsils …
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA. 1 and BA. 2 following the heterologous CoronaVac/AZD1222 …
…, S Kanokudom, C Auphimai… - Journal of Medical …, 2022 - Wiley Online Library
The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron …
…, D Srimuan, T Thatsanatorn, T Thongmee, C Auphimai… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity …
N Suntronwong, R Yorsaeng, J Puenpa, C Auphimai… - Vaccines, 2022 - mdpi.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020
…, P Nilyanimit, R Yorsaeng, C Auphimai… - Scientific reports, 2020 - nature.com
The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a major global concern. Several SARS-CoV-2 gene mutations …
coronavirus 2 (SARS-CoV-2) is a major global concern. Several SARS-CoV-2 gene mutations …
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
…, T Thongmee, P Vichaiwattana, C Auphimai… - Vaccine, 2022 - Elsevier
Limited data are available on the responses to heterologous vaccine regimens for SARS-CoV-2,
especially among countries using inactivated and adenoviral-vectored vaccines. A total …
especially among countries using inactivated and adenoviral-vectored vaccines. A total …
